Vivex Biomedical raised a round of funding on April 12, 2013. Investors include Amendia.
Vivex Biomedical is developing implant technology to help stimulate bone regrowth. Vivex has also licensed a highly adaptive adult stem cell line, known as MIAMI (Marrow Isolated Adult Multi-lineage I…
